Walgreens Boots Alliance reported a sales growth of 8.6% to $35.4 billion in FY23 Q3 with an operating loss of $0.5 billion.

The ban on animal testing on cosmetics was implemented after years of advocacy by animal welfare activists and industry leaders.

Galderma has disclosed plans to issue new shares through a private placement that is expected to raise approximately $1 billion.